Voyager Therapeutics
Price & Volume
Stats
See more52W Range | $2.64-$5.55 |
Market Cap | $165.1M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $34.4M |
Revenue Growth (YoY) | -39.1% |
Gross Profit (12 Mos) | -$81.6M |
Diluted EPS | -$1.81 |
News
See moreYahoo Finance • 3 months ago
Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026
Yahoo Finance • 3 months ago
Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s?
Yahoo Finance • 3 months ago
Cramer to a 23-Year-Old: Buy It, but It Might Take a ‘Lifetime’ to Make Money
Yahoo Finance • 4 months ago
Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference
About
CEO | Dr. Alfred W. Sandrock Jr., M.D., Ph.D. |
Address | 75 Hayden Avenue, Lexington, MA, United States, 02421 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 141 |